Deal Announcements

Kythera Keeps $10 Million Venture Capital Funding

Thursday, February 19, 2009 5:40:00 AM PDT | VentureDeal Staff

Calabasas, California  --  Biotechnology company Kythera Biopharmaceuticals has secured $10 million in its series C round of institutional venture capital financing.

Kythera uses the tools of biotechnology to develop prescription therapeutics for the aesthetic and restorative dermatology markets.

Investors in the round included Versant Ventures, Arch Venture Partners, Prospect Venture Partners, BBT Fund, Apothecary Capital, Jafco Ventures America And Altitude Life Science Ventures. The company said it would use the funding to advance clinical development of its two clinical stage compounds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1